Arcus Biosciences Inc (NYSE:RCUS)
$ 15.07 0.14 (0.94%) Market Cap: 1.37 Bil Enterprise Value: 373.93 Mil PE Ratio: 0 PB Ratio: 1.94 GF Score: 73/100

Arcus Biosciences Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 02, 2021 / 04:10PM GMT
Release Date Price: $36.27 (-1.20%)
Unidentified Analyst

Good morning, and we're just really excited to be here, and welcome to Cowen's 41st Annual Healthcare Conference. This is the Arcus Bioscience company presentation. (Operator Instructions) But today, I have the pleasure of introducing Terry Rosen, CEO; Juan Jaen, President; and Kaytee Bock, VP of IR and Corporate Strategy from Arcus.

And with that, I'll turn it over to Terry and the rest of the crew to tell us more about Arcus. Thanks for joining us.

Terry J. Rosen
Arcus Biosciences, Inc. - Co-Founder, Chairman & CEO

Thank you very much, [Eve] I was so excited I just jumped in right up there. So good morning, everybody, and thank you for your interest in Arcus and look forward to spending the next half hour or so telling you about Arcus.

For those of you that are new to Arcus, we're an oncology company. We were founded in 2015. We focus on targets where we recognized early on that molecules would be being combined with each other. And so therefore, all things being equal, we focus on programs where we could combine

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot